| 6:45 a.m. |
Registration |
| 7:30 a.m. |
Introduction by Moderators |
| 7:35 a.m. |
2022 Harry Hirsch Leiter Award Recipient:
Genipin Corneal Crosslinking Treatment in a Fusarium solani Keratitis Model
Marcela Huertas-Bello |
| 7:42 a.m. |
1. Adjunctive Treatment with Rose Bengal Photodynamic Antimicrobial Therapy for Patients with Progressive Infectious Keratitis: Outcomes of the First 100 Patients
Jordan Huang, MD, BHSc |
| 7:49 a.m. |
2. 222 nm UV Light Efficacy Against Fungal Species and Safety for Donor Corneal Endothelium
Andres Serrano, MD |
| 7:56 a.m. |
3. A Retrospective Analysis of the Outcomes of Conjunctival Flaps used to treat Infectious Corneal Ulcers
Christina N. Llaneras, BS |
| 8:03 a.m. |
4. Vision-Related Quality of Life Outcomes in Patients Treated for Filamentous Fungal Keratitis in the CLAIR Trial
Alejandro Arboleda |
| 8:10 a.m. |
5. Trends and Clinical Outcomes of Fungal Keratitis in Canada: A 20-year Retrospective Multicentre Study
Jennifer Ling, MSc, MD |
| 8:17 a.m. |
6. Demographics, Clinical Presentation, and Outcomes of Patients with Intravenous Drug Use (IVDU)-Associated Endogenous Candida Endophthalmitis
Su Jeoung Kim, MD |
| 8:24 a.m. |
7. Histopathologic Correlation between Acanthamoeba Species Recovered from Patients Who Underwent Therapeutic and Optical Penetrating Keratoplasties after Rose Bengal Photodynamic Antimicrobial Therapy
Jaime D. Martinez, MD |
| 8:31 a.m. |
8. Safety Profile of Miltefosine in Cornea and its ex vivo and in vitro Efficacy Against Acanthamoeba
Savitri Sharma, MD |
| 8:38 a.m. |
9. Patients with Neurotrophic Keratopathy Demonstrate Increased Dendritiform Cell Density and Size by in vivo Confocal Microscopy, Suggesting the Presence of Inflammation
Ana Balbuena-Pareja |
| 8:45 a.m. |
10. Characteristics of Pre-Screened Patients Who Did Not Participate in the Zoster Eye Disease Study (Zeds)
Ayodele K. Maja, BA |
| 8:52 a.m. |
11. Comparison of Pain Interference on Quality of Life in Neuropathic Corneal Pain (NCP) Patients with and without Non-ocular Facial Pain
Leyla Mirzaee, DMSc |
| 8:59 a.m. |
12. Conjunctival Optical Coherence Tomography Angiography is Associated with Ocular Redness and Corneal Dendritic Cells in Ocular Surface Disease
William Binotti, MD |
| 9:06 a.m. |
13. Chronic Inflammation as a Proposed Risk Factor for Ocular Surface Squamous Neoplasia
Sofia De Arrigunaga, MD |
| 9:13 a.m. |
14. A New Non-Contact Esthesiometer Provides Comparable Sensitivity Measurements as the Cochet-Bonnet Esthesiometer
Luiz Luciano Lamazales |
| 9:20 a.m. |
BREAK and Posters |
| 9:40 a.m. |
15. TRPV1-Dependent Corneal Resistance to Staphylococcus aureus Adhesion
Orneika Flandrin |
| 9:47 a.m. |
16. Methicillin-Resistant Staphylococcus Aureus Keratitis is Mainly Caused by Multidrug-Resistant Lineages that are Associated with Poor Outcomes
Olivia Cummings |
| 9:54 a.m |
17. Intracellular lifestyle of P. aeruginosa and Its Implications for Ofloxacin Resistance Phenotypes
Naren G. Kumar |
| 10:01 a.m. |
18. 25-Year Analysis of Antibiotic Resistance of Pseudomonas Isolates from Ocular Samples
Derek B. Chan |
| 10:08 a.m. |
19. Association of Artificial Tears with Ocular and Systemic Infection: Carbapenem-Resistant Pseudomonas Aeruginosa (VIM-GES-CRPA) Outbreak
Frida Velcani |
| 10:15 a.m. |
20. A Novel Non Toxic Ophthalmic Preservative
Gregory Schultz, PhD |
| 10:22 a.m. |
21. Outcome of Photo Dynamic Antimicrobial therapy with Rose Bengal as an Aadjuvant Treatment in the Management of Acanthamoeba keratitis: Prospective Interventional Trial
Rachel Wozniak, MD, PhD |
10:29 a.m. |
22. Activity of Cefiderocol Against Pseudomonas Aeruginosa Keratitis Isolates in vitro
Jonathan B. Mandell |
| 10:36 a.m. |
23. Cefiderocol is a Safe and Effective Topical Monotherapy for Experimental Extensively-Drug Resistant Pseudomonas Aeruginosa Keratitis
Eric G. Romanowski, MS |
| 10:43 a.m. |
24. Cefiderocol Solution is Stable at Refrigeration Temperature and Produces High Concentrations in Rabbit Corneas after Topical Therapy
Kathleen A. Yates |
| 10:50 a.m. |
25. Efficacy of a 265nm Therapeutic Ultraviolet C Beam in the Murine Model of Pseudomonas Aeruginosa Keratitis
Bhupesh Bagga, MD |
| 10:57 a.m. |
26. Use of Rose Bengal Photodynamic Therapy as a Treatment for Pseudomonas sclerokeratitis
Carolina Mercado, MD |
| 11:04 a.m. |
BREAK |
| 11:20 a.m. |
Thygeson Lecture: "Gut Microbiome and Sjogren-Syndrome
Cintia S De Paiva, MD, PhD
Associate Professor
Ocular Surface Center
Cullen Eye Institute
Ophthalmology
Baylor College of Medicine
Houston, Texas |
| 12:00 p.m. |
Closing Comments and Awards |
| 12:15 p.m. |
Business Luncheon - Crystal Lounge |
